Biotechnology Stocks I Performance Guide: Corcept Therapeutics Incorporated (CORT)
CORT has no dividends
Table and Chart of CORT Performance
See what a $1,000 investment in CORT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CORT Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $3.21 |
| End Date | Dec-01-2023 |
| End Price | $25.97 |
| # Prices | 121 |
| Min Date | May-30-2014 |
| Min Price | $2.26 |
| Max Date | Aug-31-2023 |
| Max Price | $32.73 |
| Total Return | 709.03% |
| Annualized Return | 23.04% |
| Current Value of $1,000 Purchase | $8,090 |
| Number Returns | 7,260 |
| Average Return | 175.76% |
| Number Profitable Returns | 6,304 |
| Percent Profitable Returns | 86.83% |
| Number Unprofitable Returns | 956 |
| Percent Unprofitable Returns | 13.17% |
| Profitable to Unprofitable Returns Ratio | 6.59 |
| CORT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,677,014,000 | Price to Sales | 5.95 |
| Earnings per Share | $0.8000 |
| PE Ratio | 32.46 |
| PE to Growth Ratio | 0.61 |
| Price to Book | 5.8 |
| PRICE DATA | |
| 52 Week High | $34.27 |
| 52 Week Low | $17.86 |
| Analyst Target Price | $36.83 |
| 50-Day Moving Average | $27.07 |
| 200-Day Moving Average | $25.36 |
| FINANCIAL DATA | |
| Revenue per Share | $4.291 |
| Revenue | $450,026,000 |
| Profit Margin | 20.3% |
| Return on Equity | 0.196% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CORT Compare Returns with S&P 500
CORT Trendline Chart